Roche will publish its Sales Results for the 1st Quarter of 2017 prior to the opening of the Swiss Stock Exchange on Thursday April 27th, 2017.

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website click here

Presentation slides will be posted on the Roche IR website click here

We would like to invite all interested parties to dial in as outlined below:

14:00 - 15:15 CEST / 13:00 - 14:15 BST

08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT

Conference call will start with presentations by senior management followed by a Q&A session (live access to the speakers).

Presenters:

• Severin Schwan, CEO Roche Group
• Daniel O’Day, CEO Roche Pharmaceuticals
• Roland Diggelmann, CEO Roche Diagnostics
• Alan Hippe, Chief Financial and IT Officer

To expedite the registration process on the day of the conference call, you may pre-register for the event click here

Alternatively you may dial in to the conference 10-15 min prior to the scheduled start, using the following numbers:

+41 (0) 58 310 5000 (Europe and ROW)

+44 (0) 203 059 5862 (UK)

+1 (1) 631 570 5613 (USA Toll Free)

A live audio webcast can be accessed via ir.roche.com.

A replay of the webcast will be available via ir.roche.com.